Bulletin of Semashko National Research Institute of Public HealthBulletin of Semashko National Research Institute of Public Health2415-84102415-8429FSSBI «N.A. Semashko National Research Institute of Public Health»1632Научная статьяQUALITY OF LIFE AS A CRITERION OF EFFICIENCY OF TREATMENT OF GLAUCOMA PATIENTSSakhnovS. Nvitalaxen@mail.ruKrasnodar Branch of FSAI “NMRC “ISTC “Eye Microsurgery” named after acad. S. Fyodorov” of the Ministry of Health Care of the Russian Federation151220182515714042022Copyright © 2018,2018The quality of life, along with other indicators, can comprehensively characterize the effectiveness of the treatment, including patients with glaucoma. The aim of the study was to study the quality of life of glaucoma patients after treatment with antihypertensive drugs. Material and methods. The quality of life study was conducted in 135 patients with glaucoma before and after 6 months of antihypertensive therapy by means of a questionnaire survey of the National Eye Institute Visual Functioning Questionnaire (NEI-VfQ-25) Russified version. Data processing is performed on a computer using the program "Statistica 6.0". Research result. A reliable decrease in all indicators of quality of life before treatment was established. After 6 months of conservative therapy in patients with glaucoma all indicators of quality of life increased significantly. As much as possible, such an indicator as near vision has increased. After treatment, significantly increased the perception of distance vision, General health, decreased dependence on strangers, problems with movement, pain in the eye. Conclusion. Indicators of quality of life are an important criterion for the effectiveness of treatment of patients with glaucoma.quality of lifeglaucomatreatment effectivenessкачество жизниглаукомаэффективность лечения[Агаева Р.Б. Динамика показателей инвалидности вследствие болезней глаза в оценке эффективности диспансеризации населения Азербайджана. // Казанский медицинский журнал. -2017. -Т. 98. № 3. -С. 376-381.][Бирич Т.А. Современные тенденции в лечении глауком. // Рецепт. - 2007. - № 44(54).-С. 40-44.][Голубов К.Э. Комплексный подход к оценке качества жизни пациентов с контузионной травмой органа зрения. // Клиническая медицина. - 2013. - № 5. - С.32-34.][Горынина О.А. Комплексное медико-социальное исследование по сохранению трудоспособности работников железнодорожного транспорта при глаукоме. Автореф. дисс.. канд. ме. наук. 2011, Воронеж. 24 с.][Илларионова А.Р. Исследование качества жизни у больных глаукомой. // Вестник офтальмологии. - 2003. - № 3. - С. 11-15.][Киселева О.А. Результаты исследования эпидемиологических особенностей первичной открытоугольной глаукомы в Российской Федерации - обзор тенденций 2013 года. // Российский офтальмологический журнал. - 2013. - № 3. - С. 4-7.][Маркелова Е.В. Особенности иммунопатогенеза и дополнительные дифференциальные маркеры первичной открытоугольной и первичной закрытоугольной глауком. / Е.В. Маркелова, А.С. Хохлова, А.В. Кириенко и др. // Журнал научных статей Здоровье и образование в XXI веке. - 2016ю - № 18(2). - С. 613-621.][Abdolrahimzadeh S. Rare Diseases Leading to Childhood Glaucoma: Epidemiology, Pathophysiogenesis, and Management. / S. Abdolrahimzadeh, V. Fameli, R. Mollo, Met al. // Biomed Res Int. -2015. - P. 781294.][Aziz A. Epidemiology and clinical characteristics of primary congenital glaucoma. / A. Aziz, O. Fakhoury, F. Matonti et al. // J Fr Ophtalmol. - 2015. - N.38(10). - P. 960-966.][Lazcano-Gomez G. J Neovascular Glaucoma: A Retrospective Review from a Tertiary Eye Care Center in Mexico. / G. Lazcano-Gomez, R. Soohoo // J Curr Glaucoma Pract. - 2017. -N.11(2). - P. 48-51.][Levkovitch-Verbin H. The Maccabi Glaucoma Study: prevalence and incidence of glaucoma in a large israeli health maintenance organization. / H. Levkovitch-Verbin, I. Goldshtein, G. Chodick et al. // Am J Ophthalmol. - 2014. - N. 158(2). - P. 402-408.][Liao N. Neovascular glaucoma: a retrospective review from a tertiary center in China / N. Liao, C. Li, H. Jiang, et al. // BMC Ophthalmol. - 2016. - N.16. - P. 14.][Mirzaei M. Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes. / M. Mirzaei, V.B. Gupta, J.M. Chick // Sci Rep. - 2017. - N. 7(1). - P. 12685.][Tham YC. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and metaanalysis. / Y.C. Tham, X. Li, T.Y. Wong, et al. // Ophthalmology. - 2014. -N. 121. - P. 2081-2090.][Wostyn P. The Glymphatic Hypothesis of Glaucoma: A Unifying Concept Incorporating Vascular, Biomechanical, and Biochemical Aspects of the Disease. / P. Wostyn, V. De Groot, D. Van Dam et al. // Biomed Res Int. - 2017. - P. 5123148.][Zhao Y. Epidemiology and clinical characteristics of patients with glaucoma: An analysis of hospital data between 2003 and 2012. / Y. Zhao, J.L. Fu, Y.L. Li et al // Indian J Ophthalmol. - 2015. - N. 63(11).-P. 825-831]